Viral kinetics of hepatitis C virus according to IL28b and its effect on sustained virological response (SVR) with respect to triple therapy of telaprevir, peg-interferon, and ribavirin.
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Peginterferon (Primary) ; Ribavirin (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Dec 2015 New trial record